Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) rarely cause euglycemic diabetic ketoacidosis (euDKA) in diabetic patients. The aim was to identify demographic, clinical, and predisposing factors for euDKA from published case reports. Methods: A systematic review of publishe...
Main Authors: | Siddhartha Dutta, Tarun Kumar, Surjit Singh, Sneha Ambwani, Jaykaran Charan, Shoban B Varthya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=3;spage=927;epage=940;aulast=Dutta |
Similar Items
-
Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?
by: Georgios Pilianidis, et al.
Published: (2024-02-01) -
Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis
by: Julia Selwyn, et al.
Published: (2023-02-01) -
Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population
by: Azza B. El-Remessy
Published: (2022-12-01) -
Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report
by: Venkata Vinod Kumar Matli, et al.
Published: (2021-12-01) -
Euglycemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors after surgery: A case report and review of literature
by: Mei-An Pai, et al.
Published: (2023-01-01)